The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 January 19, 2006
 Audio Icon Audio Summary
*
Correspondence
* Antipsychotic Drugs and Schizophrenia
* Vasodilators in Aortic Regurgitation
* Childhood Growth and Coronary Events
* Asbestos Exposure and Serum Osteopontin
* Malignant Mesothelioma
* Immunologic Tolerance to Intravenously Injected Insulin
*
Book Reviews
* Marked in Your Flesh: Circumcision from Ancient Judea to Modern America
A Surgical Temptation: The Demonization of the Foreskin and the Rise of Circumcision in Britain
* Terrors of the Table: The Curious History of Nutrition
Original Articles
Long-Term Hypertonic Saline in Patients with Cystic Fibrosis

Patients with cystic fibrosis have inspissated mucus that is thought to contribute to the pulmonary exacerbations characteristic of the disease. As compared with treatment with normal saline, twice-daily treatment with inhaled hypertonic saline after the inhalation of a bronchodilator did not affect the linear rate of change in the forced expiratory volume in one second (FEV1) but was associated with improved FEV1 values and with fewer and shorter pulmonary exacerbations.

Related Editorial


Original Articles
Hypertonic Saline in Cystic Fibrosis

Inhalation of hypertonic saline has a modest beneficial effect on lung function and the frequency of exacerbations in patients with cystic fibrosis. In this article, the investigators provide in vivo and in vitro data suggesting that this therapeutic effect derives from sustained acceleration of mucus clearance.

Related Editorial


Original Articles
Tenofovir and Emtricitabine vs. Zidovudine and Lamivudine for HIV

This randomized, open-label trial compared two regimens for the initial treatment of human immunodeficiency virus (HIV) infection: tenofovir disoproxil fumarate and emtricitabine plus efavirenz or a fixed dose of zidovudine and lamivudine plus efavirenz. Through week 48, the first regimen was superior in terms of viral suppression, CD4-cell response, and adverse events leading to discontinuation of the medication. As this trial continues, it will be important to assess any differences in long-term toxic effects, especially with regard to lipoatrophy and hyperlipidemia.


Original Articles
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

Women with the Lynch syndrome (hereditary nonpolyposis colorectal cancer) are at high risk for endometrial cancer and at increased risk for ovarian cancer. In this retrospective cohort study, there were no cases of either cancer among women who underwent prophylactic hysterectomy with bilateral salpingo-oophorectomy, as compared with women who did not undergo prophylactic surgery. The risk reduction was significant for endometrial cancer, although not for ovarian cancer. These results support the consideration of prophylactic hysterectomy with bilateral salpingo-oophorectomy to reduce the risk of cancer in women with the Lynch syndrome.

Related Editorial


Review Article
Mechanisms of Disease: Estrogen Carcinogenesis in Breast Cancer

Estrogen exposure is a major determinant of the risk of breast cancer. This article reviews how genotoxic, mutagenic metabolites of estrogen and stimulation of tissue growth by the hormone participate in the pathogenesis of breast cancer.


Case Records of the Massachusetts General Hospital
An HIV-Positive Man with Rectal Pain

A 31-year-old HIV-positive man was seen in the clinic because of four days of rectal pain on defecation, with a mucopurulent rectal discharge. He was homosexual and had regular anal-receptive sex with multiple partners.


Clinical Implications of Basic Research
Targeting Virulence

Effective treatment of a mouse model of cholera demonstrates a new strategy for developing antibiotics: targeting the expression of virulence proteins.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.